|
Market Cap (18-May) $26,586,560 (621st) |
Close (30-Jun) $0.58 |
Volume (30-Jun) 102,948 |
Shortsold (3-Jul) 1,500 (0.00%) (620th) |
|
52w High $0.315 |
52w Low $0.081 |
P/E 128.21 |
EPS -0.06 |
NXS released this announcement to the ASX on 27 May 2022, 12:51. The announcement is not marked as price sensitive, and is 2 page(s) in length and 172.67kb in size.
You can view all announcements from NXS and see how they appear on a price chart on the announcements page.
At the date of this announcement, NXS was 0.001% short sold according to ASIC data. It was ranked the 695th most shorted stock on the ASX. It is now ranked as the 620th most shorted stock on the ASX with 0.001% of total shares short sold as of the latest reported data (03 July 2024).
| Other Recent Announcements from NXS | |
|---|---|
| Director Retirement | 30 June 2023, 9:09 |
| Market Update | 29 June 2023, 9:44 |
| Appointment of new Managing Director and CEO | 16 June 2023, 8:25 |
| 2022 AGM - Voting Results | 27 May 2022, 12:51 |
| AGM Chair & Managing Director Addresses | 27 May 2022, 9:25 |
| Next Science to strengthen senior leadership presence in US | 27 May 2022, 9:17 |
| Oraderm Pharmaceuticals appointed as BlastX distributor | 19 May 2022, 11:39 |
You must be logged in to post a reply.
Next Science 